Results for tag: "Protein Misfolding"

Protein misfolding is a phenomenon in proteomics, the study of proteins, where proteins do not fold into their correct three-dimensional structure. This can lead to a variety of diseases, such as Alzheimer's, Parkinson's, and Huntington's. Protein misfolding can also cause a range of other diseases, such as cystic fibrosis and type 2 diabetes. As such, the market for protein misfolding research is growing rapidly. The market for protein misfolding research is driven by the need to develop treatments for diseases caused by misfolded proteins. Companies in the market are researching ways to detect misfolded proteins, develop treatments, and develop drugs to prevent misfolding. Companies are also researching ways to use protein misfolding as a diagnostic tool. Companies in the protein misfolding market include AbbVie, Amgen, AstraZeneca, Biogen, Celgene, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more